Aging is a weak but relentless determinant of dementia severity

Oncotarget

Volumn 7, Issue 12, 2016, Pages 13307-13318

  Royall, Donald R ^a,b,c   Palmer, Raymond F ^b  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Aging; Dementia; Gerotarget; Intelligence; Senility

Indexed keywords

APOLIPOPROTEIN E4; HEMOGLOBIN A1C; HOMOCYSTEINE;

ADULT; AGE; AGED; AGING; AMINO ACID BLOOD LEVEL; ARTICLE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; ETHNICITY; FEMALE; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIFESPAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UNITED STATES; COGNITIVE DEFECT; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; COGNITION DISORDERS; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84971595444     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7759     Document Type: Article

References (58)

1. Chelune, G.J., & Duff, K. . The Assessment of Change: Serial Assessments in Dementia Evaluations in Lisa D. Ravdin & Heather L. Katzen (Eds.) Handbook on the Neuropsychology of Aging and Dementia Clinical Handbooks in Neuropsychology, Springer, New York,. 2013; 43-57, 2013.
2. Reitz, C., & Mayeux, R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochemical Pharmacololgy. 2014;. 88: 640-651.
3. McGue, M. & Christensen, K. . Heritability of level of and rate of change in cognitive functioning in Danish twins aged 70 years and older. Experimental Aging Research. 2002; 28:435-451.
4. Reynolds, C.A., Finkle, D., Gatz, M., Pedersen, N.L. (2002). Sources of influence on rate of cognitive change over time in Swedish twins: An application of latent growth models. Experimental Aging Research. 2002; 28: 407-433.
5. Ghisletta, P., & Lindenberger, U. Static and dynamic longitudinal structural analyses of cognitive changes in old age. Gerontology. 2004; 50:12-16.
6. Royall, D.R., Palmer, R.F., Chiodo, L.K., Polk, M. Towards an Aging Specific Cognitive Phenotype: The Freedom House Study. Experimental Aging Research. 2014; 40:245-265.
7. Lawton, M.P., & Brody, E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9:179-186.
8. Royall, D.R., & Palmer, R.F. Getting Past "g": Testing a new model of dementing processes in non-demented persons. Journal of Neuropsychiatry and Clinical Neurosciences. 2012; 24:37-46.
9. Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A., Martin, R.L. A new clinical scale for the staging of dementia. British Journal of Psychiatry. 1982; 140: 566-572.
10. Royall, D.R., Palmer, R.F., O'Bryant, S.E Validation of a latent variable representing the dementing process. Journal of Alzheimer's Disease 2012; 30: 639-649.
11. Spearman, C., Wynn Jones, L.L. Human Ability, Macmillan & Co., London.
12. Royall, D.R., Palmer, R.F., Vidoni, E.D., Honea, R.A. The Default Mode Network may be the Key Substrate of Depression Related Cognitive Changes. Journal of Alzheimer's Disease 2013; 34: 547-560.
13. Royall, D.R., Matsuoka, T., Palmer, R.F., Kato, Y., Taniguchi, S., Ogawa, M., Fujimoto, H., Okamura, A., Shibata, K., Nakamura, K., Nakaaki, S., Koumi, H., Mimura, M., et al. Greater than the sum of its parts: δ Improves upon a battery's diagnostic performance. Neuropsychology. 2015; 29: 683-692.
14. Gavett, B.E., Vudy, V., Jeffrey, M., John, S.E., Gurnani, A., Adams, J. The δ latent dementia phenotype in the NACC UDS: Cross-validation and extension. Neuropsychology 2015; 29:344-352.
15. Kraemer, H.C., Stice, E., Kazdin, A., Offord, D., Kupfer, D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry. 2001; 158: 848-856.
16. Palmer, R.F., & Royall, D.R. Future Dementia Status is Almost Entirely Explained by the Latent Variable δ's Intercept and Slope. Journal of Alzheimer's Disease 2016; 49:521-529.
17. Royall, D.R., & Palmer, R.F. δ Scores Predict MCI and AD Conversions from Non-Demented States. Journal of Prevention of Alzheimer's Disease 2015; 2:337-338.
18. Sobel, E., Louhija, J., Sulkava, R., Davanipour, Z., Kontula, K., Miettinen, H., Tikkanen, M., Kainulainen, K., Tilvis, R. Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology. 1995; 45:903-907.
19. Corrada, M.M., Paganini-Hill, A., Berlau, D.J., Kawas, C.H. Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study. Alzheimers & Dementia. 2013; 9:12-18.
20. Valerio, D., Raventos, H., Schmeidler, J., Beeri, M.S., Villalobos, L.M., Bolaños-Palmieri, P., Carrión-Baralt, J.R., Fornaguera, J., Silverman, J.M. Association of apolipoprotein E-e4 and dementia declines with age. American Journal of Geriatric Psychiatry. 2014; 22: 957-960.
21. Corrada, M.M., Brookmeyer, R., Paganini-Hill, A., Berlau, D., Kawas, C.H. Dementia incidence continues to increase with age in the oldest old: the 90+ study. Annals of Neurology. 2010; 67:114-121.
22. von Gunten, A., Ebbing, K., Imhof, A., Giannakopoulos, P., Kövari, E. Brain aging in the oldest-old. Currents in Gerontology and Geriatric Research. 2010;. pii: 358531. doi: 10.1155/2010/358531.
23. Snowdon, D.A., Kemper, S.J., Mortimer, J.A., Greiner, L.H., Wekstein, D.R., Markesbery, W.R. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. Journal of the American Medical Association 1996; 275: 528-532.
24. Cooper, C., Sommerlad, A., Lyketsos, C.G., Livingston, G. Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. American Journal of Psychiatry. 2015; 172: 323-334.
25. Gavett, B.E., John, S.E., Gurnani, A.S., Bussell, C.A., Saurman, J.L. The role of Alzheimer's and cerebrovascular pathology in mediating the effects of age, race, and apolipoprotein E genotype on dementia severity in pathologically confirmed Alzheimer's disease. Journal of Alzhiemer's Disease. 2016; 49:531-545.
26. Crary, J.F., Trojanowski, J.Q., Schneider, J.A., Abisambra, J.F., Abner, E.L., Alafuzoff, I., Arnold, S.E., Attems, J., Beach, T.G., Bigio, E.H., Cairns, N.J., Dickson, D.W., Gearing, M., et al. Primary age-related tauopathy (PART): A common pathology associated with human aging. Acta Neuropathologica. 2014; 128: 755-766.
27. Royall, D.R., Palmer, R.F., Vidoni, E.D., Honea, R.A., Burns, J.M. The Default Mode Network and related right hemisphere structures may be the key substrates of dementia. Journal of Alzheimer's Disease, 2012; 32, 467-478.
28. Royall, D.R., Palmer, R., Mulroy, A., Polk, M.J., Román, G.C., David, J.-P., Delacourte, A. Pathological determinants of clinical dementia in Alzheimer's disease. Experimental Aging Research. 2002; 28: 143-162.
29. Royall, D.R. Location, location, location! Neurobiology of Aging, 2007; 28: 1481-1482.
30. Royall, D.R., & Palmer, R.F. Serum IGF-BP2 Strongly Moderates Age's Effect on Cognition: A MIMIC Analysis. Neurobiology of Aging. 2015; 36: 2232-2240.
31. Royall, D.R., & Palmer, R.F. Ethnicity Moderates Dementia's Biomarkers. Journal of Alzheimer's Disease. 2015; 43: 275-287.
32. Shaw, A.C., Panda, A., Joshi, S.R., Qian, F., Allore, H.G., Montgomery. R.R. Dysregulation of human Toll-like receptor function in aging. Ageing Research Reviews. 2011; 10: 346-353.
33. Bongaarts, J. Human population growth and the demographic transition. Philosophical Transactions of the Royal Society London B Biological Sciences. 2009; 364: 2985-2990.
34. Waring, S., O'Bryant, S.E., Reisch, J.S., Diaz-Arrastia, R., Knebl, J., Doody, R., for the Texas Alzheimer's Research Consortium. The Texas Alzheimer's Research Consortium longitudinal research cohort: Study design and baseline characteristics. Texas Public Health Journal. 2008; 60; 9-13.
35. McKhann, D., Drockman, D., Folstein, M. Katzman, R., Price, D., Stadlan, E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group. Neurology. 1984; 34: 939-944.
36. Wechsler, D. Wechsler Memory Scale - Third Edition. San Antonio, TX: The Psychological Corporation.
37. Benton, A., & Hamsher, K. (1989). Multilingual Aphasia Examination. AJA Associates, Iowa City, Iowa. 1989
38. Morris, J.C., Heyman, A., Mohs, R.C., Hughes, J.P., vanBelle, G., Fullenbaum, G., Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease, Part 1: Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989; 39:1159-1165.
39. Kaplan, E.F., Goodglass, H., & Weintraub, S. The Boston Naming Test. Experimental edition. Boston: Kaplan & Goodglass. 2nd ed., Lea & Febiger. Philadelphia.
40. Rosen, W.G., Mohs, R.C., Davis, K.L. A new rating scale for Alzheimer's disease. American Journal of Psychiatry. 1984; 141: 1356-1364.
41. Reitan, R.M. (1958). Validity of the Trail Making test as an indicator of organic brain damage. Perceptual & Motor Skills. 1958; 8: 271-276.
42. Yesavage, J.A., Brink, T.L., Rose, T.L., Lum, O., Huang, V., Adey, M., Leirer, V.O. Development and validation of a geriatric depression screening scale: A preliminary report. Journal of the American Geriatrics Society. 1982; 29: 164-171.
43. Maixner, S.M., Burke, W.J., Roccaforte, W.H., Wengel, S.P., Potter, J.F. A comparison of two depression scales in a geriatric assessment clinic. American Journal of Geriatric Psychiatry. 1995; 3: 60-67.
44. Koch, W., Ehrenhaft, A., Griesser, K., Pfeufer, A., Muller, J., Schomig, A., Kastrati, A. TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clinical Chemistry and Laboratory Medicine. 2002; 40: 1123-1131.
45. Folstein, M.F., Folstein, S.E., & McHugh, P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975; 12: 189-198.
46. Arbuckle, J.L. Analysis of Moment Structures-AMOS (Version 7.0) [Computer Program], SPSS, Chicago. 2006.
47. Grice, J.W. Computing and evaluation factor scores. Psychological Methods. 2001; 6:430-450.
48. MacKinnon, D. Analysis of mediating variables in prevention and intervention research. In: Czarees A, Beatty L (editors) Scientific methods for prevention intervention research. NIDA Research Monograph. 1994; 139:137-153.
49. Palmer, R.F., & Royall, D.R. Missing data? Plan on it! Journal of the American Geriatric Society. 2010; 58:S343-348.
50. PASW Statistics 18, Release Version 18.0.0, SPSS, Inc., Chicago, IL. 2009
51. Schafer, J.L., & Graham, J.W. Missing data: Our view of the state of the art. Psychological Methods. 2002;7: 147-177.
52. Graham, J.W. Missing Data Analysis: Making it work in the real world. Annual Review of Psychology. 2009; 6: 549-576.
53. Bollen, K.A., & Long, J.S. Testing Structural Equation Models. Sage Publications, Thousand Oaks, CA. 1993
54. Wheaton, B., Muthén, B., Alwin, D.F., Summer, G.F. Assessing reliability and stability in panel models. In D.R.Heise (Ed.) Sociology Methodology San Francisco, CA: Jossey-Bass. 1977
55. Bentler, P.M. Comparative fit indexes in structural models. Psychological Bulletin. 1990; 107: 238-246.
56. Browne, M., & Cudeck, R.. Alternative ways of assessing model fit. In Testing structural equation models, in Bollen KA, Long JS, eds. Sage Publications, Thousand Oaks, CA. 1993; pp. 136-162.
57. Metz, C.E. Basic principles of ROC analys. Sem Nuc Med 8, 283-298.Cognitive Impairment. Journal of Internal Medicine. 1978; 256:240-246.
58. Zweig, M.H., & Campbell, G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clinical Chemistry. 1993; 39:561-577.